Table 5 The impact of embryo biopsy on health outcomes at 2 years
EBD5 FET N=57 | EBD3 FET N=128 | EBD3 FRESH N=140 | Non-biopsy FET N=150 | Non-biopsy FRESH N=131 | |
|---|---|---|---|---|---|
Developmental disorder | |||||
Mild | 4 (7.0) | 6 (4.7) | 5 (3.6) | 9 (6) | 5 (3.8) |
Severe | 1 (1.7) | 2 (1.6) | 2 (1.4) | 4 (2.6) | 3 (2.3) |
Hospital admission | |||||
At least once | 17 (29.8) | 31 (24.2) | 35 (25.0) | 40 (26.6) | 31 (23.6) |
Chronic medication use | |||||
Yes | 6 (10.5) | 14 (10.9) | 13 (9.3) | 17 (11.3) | 14 (10.7) |
Surgical intervention | |||||
Yes | 5 (8.8)* | 20 (15.6) | 18 (12.8) | 32 (21.3) | 18 (13.7) |
For congenital malformation | 1 | 6 | 5 | 5 | 3 |
Other reason | 4 | 14 | 13 | 27 | 15 |